Administering the SR9011 and SR9009 compounds to alter the activity of circadian rhythms helped obese mice lose weight and attain a 47% decrease in cholesterol levels and a 12% reduction in blood triglycerides, a study in Nature found. The findings suggest that drugs that affect the brain's biological clock may help address obesity and diabetes, researchers said.

Full Story:

Related Summaries